RNC Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$7.62M Sell
13,149
-417
-3% -$236K 0.35% 47
2025
Q3
$6.58M Buy
13,566
+77
+0.6% +$35.8K 0.3% 49
2025
Q2
$5.47M Buy
13,489
+2,472
+22% +$1.03M 0.27% 51
2025
Q1
$5.48M Buy
11,017
+1,237
+13% +$670K 0.28% 51
2024
Q4
$5.09M Sell
9,780
-1,913
-16% -$1.05M 0.27% 52
2024
Q3
$6.47M Hold
11,693
0.36% 46
2024
Q2
$6.47M Buy
11,693
+1,157
+11% +$663K 0.36% 46
2024
Q1
$6.12M Buy
10,536
+2,200
+26% +$1.23M 0.35% 48
2023
Q4
$4.42M Sell
8,336
-118
-1% -$57.1K 0.27% 52
2023
Q3
$4.28M Buy
+8,454
New +$4.5M 0.27% 52

Other funds holding TMO

RNC Capital Management's TMO Position: Q4 2025 in Review

RNC Capital Management reduced its Thermo Fisher Scientific (TMO) stake by 3.1% in Q4 2025, selling an estimated $236K and leaving 13,149 shares worth $7.62M. The position accounts for 0.35% of the portfolio, ranked #47.

RNC Capital Management first reported a position in TMO in Q3 2023 and has held it in 10 quarters since. 2,699 funds tracked by Wall St. Rank hold TMO as of Q4 2025.

  • RNC Capital Management held 13,149 shares of Thermo Fisher Scientific worth $7.62M as of Q4 2025.
  • RNC Capital Management sold 417 Thermo Fisher Scientific shares in Q4 2025, an estimated $236K.
  • Thermo Fisher Scientific made up 0.35% of RNC Capital Management's portfolio in Q4 2025, its #47 holding.
  • RNC Capital Management first reported a position in Thermo Fisher Scientific in Q3 2023 and has held it in 10 quarters since.
  • 2,699 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2025.

Based on RNC Capital Management's 13F filing for Q4 2025, filed 3 Feb 2026.